Scarica l'app Stockscreener
2.14
5.42%
0.11
Dopo l'orario di chiusura:
2.14
Harvard Bioscience Inc Borsa (HBIO) Ultime notizie
State Street Corp Acquires 7,763 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
HBIO stock touches 52-week low at $1.99 amid market challenges - Investing.com Nigeria
Lexaria Bioscience Forms Elite Scientific Advisory Board with Harvard Medical School Expert - StockTitan
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience - Yahoo Finance
BNP Paribas Financial Markets Has $201,000 Stock Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
BNP Paribas Financial Markets Boosts Stock Position in Ovid Therapeutics Inc. (NASDAQ:OVID) - Defense World
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Update - Defense World
Harvard Bioscience (HBIO) Stock Dips Amid Industry Movements - GuruFocus.com
Harvard Bioscience (NASDAQ:HBIO) Stock Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Harvard Bioscience (HBIO) Stock Drops Amid Market Volatility - GuruFocus.com
3 US Penny Stocks With Market Caps Under $100M - Simply Wall St
Harvard Bioscience files $100M mixed securities shelf - MSN
In-Vitro and In-Vivo Micro Electrode Array Market to Grow by USD 7 Million (2024-2028), Driven by MEA Applications in Neuroscience Research, with AI Driving Market TransformationTechnavio - The Malaysian Reserve
272 Capital LP Has $1.54 Million Position in Harvard Bioscience, Inc. (NASDAQ:HBIO) - MarketBeat
Harvard Bioscience (HBIO) Stock Surges Amid Positive Analyst Rat - GuruFocus.com
HBIO stock touches 52-week low at $1.99 amid market challenges By Investing.com - Investing.com South Africa
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 13.8% in October - MarketBeat
Ayla Majid becomes first South Asian ACCA president - The Accountant Online
Harvard Bioscience (HBIO) Stock Drops Amid Industry Downturn - GuruFocus.com
272 Capital LP Increases Stake in Harvard Bioscience Inc - GuruFocus.com
HBIO stock touches 52-week low at $2.29 amid market challenges - Investing.com India
Harvard Bioscience (HBIO) Stock Dips Amid Market Volatility - GuruFocus.com
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript - Insider Monkey
Harvard Bioscience Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Harvard Bioscience (HBIO) Stock Surges with Positive Analyst Rat - GuruFocus.com
Harvard Bioscience Inc (HBIO) Quarterly 10-Q Report - Quartzy
SEC Form 10-Q filed by Harvard Bioscience Inc. - Quantisnow
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada
Harvard Bioscience: Q3 Earnings Snapshot - CT Insider
Harvard Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
3 Promising US Penny Stocks With At Least $100M Market Cap - Simply Wall St
Harvard Bioscience Inc Reports Q3 2024 Revenue of $22.0M, Misses Estimates; EPS Loss of $0.11 - GuruFocus.com
Harvard Bioscience : Q32024 HBIO Quarterly Earnings Presentation - Marketscreener.com
Harvard Bioscience Announces Third Quarter 2024 Financial Results - GlobeNewswire
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: W - GuruFocus.com
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Is It Too Late To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)? - Yahoo Finance
Zacks Industry Outlook Highlights Mettler-Toledo International and Harvard Bioscience - Yahoo Finance
Harvard Bioscience (HBIO) Set to Announce Earnings on Thursday - MarketBeat
Moolec Science (MLEC) versus Its Rivals Head-To-Head Comparison - Defense World
Chegg, Inc. (NYSE:CHGG) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
2.64%
0.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):